Target intelligence / Profile preview

Lysyl-tRNA synthetase 1 pseudogene 2 (KARS1P2)

Target: KARS1P2
Molecular classification: Other (classified as a pseudogene; not an enzyme, receptor, transporter, etc.)

Overview

Lysyl-tRNA synthetase 1 pseudogene 2 (KARS1P2) is a pseudogene related to the lysyl-tRNA synthetase (LysRS) family; it does not encode a functional protein and has no reported biological, disease, or drug-targeting role. LysRS is an enzyme responsible for attaching lysine to its corresponding tRNA during protein synthesis, but KARS1P2 is an inactive pseudogene rather than a functional enzyme[1]. Thus, it is not considered a therapeutic target.

Other names: KARSP2lysyl-tRNA synthetase pseudogene 2KARS1P2

Mechanism of action

null (no mechanism, since there is no functional protein produced)

Biological functions

null (pseudogenes have no known biological function unless specifically reactivated or re-functionalized, which is not reported for KARS1P2)

Disease associations

null (no direct implication in disease reported)

Safety considerations

null (no therapeutic targeting or known safety considerations)

Interacting drugs

null (no drug is known to interact with KARS1P2, as it does not produce a targetable protein)

Biomarkers

null (no biomarker utility reported)

Beyond the preview

Go deeper on Lysyl-tRNA synthetase 1 pseudogene 2 (KARS1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysyl-tRNA synthetase 1 pseudogene 2 (KARS1P2).

Explore the full profile